Patients with follicular lymphoma have a high rate of relapse, even after rituximab-based combination regimens with chemotherapy. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact …
A growing proportion of the readers, authors, reviewers, and staff members are non-European.Since we are now number eight of all surgical journals (just behind the We also publish educational articles, editorials, and letters in the main journal, although they have no influence on the journal impact factor.
FMS-like tyrosine kinase 3 (FLT3) somatic mutations are common driver mutations in acute leukemia.Yang et al used three-dimensional (3D) modeling to demonstrate that a subset of acute lymphoblastic leukemia harbors a small deletion in chromosome 13q12.2, leading to the … 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking. Quartile de facteur d'impact Blood advances: - .Un facteur d'impact, également abrégé par les sigles FI ou IF (pour l'anglais : impact Metric), est un indicateur qui estime indirectement la visibilité d'une revue scientifique.Le FI d'une revue est le nombre moyen de citations de chaque article publié dans cette revue. Becoming the premier scientific journal in our field does not exclude other important functions. Patients undergoing umbilical cord blood transplantation are known to have slower platelet engraftment, which can be associated with bleeding risk and an ongoing need for platelet transfusions. Strati and colleagues detail the clinical, electroencephalographic, and radiographic features of ICANS and discuss the association between severe ICANS and outcomes.
360 impact factor in JCR 2018. However, it was unclear how this risk stratification impacted outcomes after allogeneic transplantation. Blood Pressure.
Gleadall and colleagues developed a single, accurate, universal, unified DNA-based testing system that could be readily adopted to identify red blood cell, platelet, and white blood cell antigens.
We do encourage debates and invite our readers to write letters on controversial hot topics. The treatment of patients with Waldenström macroglobulinemia (WM) continues to evolve.
The ESVS management guidelines for carotid disease contributed with the highest number of citations.
In 2017, the European LeukemiaNet updated guidelines for allocating patients with acute myelogenous leukemia (AML) into 3 different risk groups based upon cytogenetic and molecular alterations. Immune effector cell–associated neurotoxicity syndrome (ICANS) is a frequent and occasionally morbid side effect of chimeric antigen receptor T-cell therapy.
Blood transfusions are used worldwide and save many lives. Blood advances Journal Impact (Facteur d'impact) 2019: - .
When the journal impact factor is calculated every single article counts; on average, each EJVES paper published in 2017 or 2018 was cited more than five times during 2019. In this issue, Castillo and colleagues update the very favorable long-term outcomes of patients with WM treated with the combination of ixazomib, dexamethasone, and rituximab, which is a safe and effective regimen for upfront treatment of patients with this disorder. A common feature for all these documents is that they attract scientific and clinical interest not only among vascular surgeons, but also among professionals of many other medical specialities. Grimm and colleagues addressed this question, providing important new information on the outcomes of patients with AML. Vascular surgery is a speciality with fast development. When the journal impact factor is calculated every single article counts; on average, each Still, some well-cited papers deserve to be mentioned.
Sickle cell disease is the most common inherited blood disorder in the United States.
Scientific publishing is a moving target undergoing rapid change. ISSN: …
2019 Impact Factor. International Scientific Journal & Country Ranking. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received.
Tang and colleagues performed a randomized trial of thrombopoietin in patients to attempt to accelerate platelet recovery and made important clinical findings. The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Maloney and colleagues describe results from the phase 3 HOMER trial comparing rituximab vs ofatumumab, a novel anti-CD20–directed monoclonal antibody targeting a different epitope than rituximab. Blood Impact Factor, IF, number of article, detailed information and journal factor. However, access to care and standardization of treatment are major issues in the care of these often-complex patients.